April 21, 2025 reference-entry Myasthenia Gravis Elsevier eBooks DOI: 10.1016/b978-0-12-824465-4.00172-1 OpenAlex Authors 0 Author list not loaded yet. Cited by 0 stored of 0 References 4 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Factors affecting IgG4-mediated complement activation 2023 Frontiers in Immunology article Immunology and Microbiology Complement system in diseases Open access 56 citations IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies 2022 Frontiers in Immunology article Medicine IgG4-Related and Inflammatory Diseases Open access 42 citations The ClC-1 chloride channel inhibitor NMD670 improves skeletal muscle function in rat models and patients with myasthenia gravis 2024 Science Translational Medicine article Medicine Myasthenia Gravis and Thymoma Open access 33 citations Factor B Inhibition with Oral Iptacopan Monotherapy Demonstrates Sustained Long-Term Efficacy and Safety in Anti-C5-Treated Patients (pts) with Paroxysmal Nocturnal Hemoglobinuria (PNH) and Persistent Anemia: Final 48-Week Results from the Multicenter, Phase III APPLY-PNH Trial 2023 Blood conference-abstract Immunology and Microbiology Complement system in diseases 14 citations 4 results